1. Губкин Н.В.; Звонков Е.Е.; Кременецкая А.М.; и соавт. Первичные лимфопролиферативные заболевания центральной нервной системы. Терапевтический архив. 2009; 7: 85-91.
1. Миненко С.В.; Ларина Ю.В.; Птушкин В.В.; и соавт. Лечение лимфом центральной нервной системы – обзор литературы и собственные данные. Онкогематология. 2011; 3:50-57. 2. Abrey L.E.; Batchelor T.; Ferreri A.J. et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005; 23: 5034-43. 3. Bataille B.; Delwail V.; Menet E. et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000; 92(2): 261-6. 4. Batchelor T.; Carson K.; O"Neill A. et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol. 2003; 21(6): 1044-9. 5. Chamberlain M.C.; Johnston S.K. High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma. Neuro Oncol. 2010; 12(7): 736-44. 6. DeAngelis L.M.; Seiferheld W.; Schold S.C. et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002; 20 (24):4643-8. 7. Ferreri A.; Verona C.; Politi L. Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2011; 80(1): 169-75; 8. Ferreri A.J.; Blay J.Y.; Reni M. et al. Prognostic scoring system for primary CNS lymphoma: The International Extranodal Lymphoma Study Group Experience. J Clin Oncol. 2003; 21: 266-272. 9. Ferreri A.J.; Reni M.; Foppoli M. et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 2009; 374(9700): 1512-20. 10. Ferreri A.J.; Reni M.; Pasini F. et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002; 58 (10): 1513-11520. 11. Ferreri A.J.; Reni M.; Zoldan M.C. et al. Importance of complete staging in non-Hodgkin’s lymphoma presenting as a cerebral mass lesion. Cancer. 1996; 77(5): 827-833. 12. Ferreri A.J. How I treat primary CNS lymphoma. Blood. 2011; 118: 510-522. 13. Fischer L.; Thiel E.; Klasen H.A. et al. Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol. 2006; 17(7): 1141-1145. 14. Gavrilovic I.T.; Hormigo A.; Yahalom J. et al. Long-term follow-up of high-dose methotrexatebased therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006; 24(28): 4570-4. 15. Khan R.B.; Shi W.; Thaler H.T. et al. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol. 2002; 58(2): 175-178. 16. Knowels D.M. Etiology and pathogenesis of AIDS-related lymphoma. Hematol Oncol Clin North Am. 2003; 17: 785-820. 17. Marturano E.; Ferreri A.J. Primary CNS lymphoma in immunocompetnt patients. Ann Oncol. 2011; 22(suppl. 4): 20-23. 18. Nguyen P.L.; Chakravarti A.; Finkelstein D.M. et al. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005; 23(7): 1507-13. 19. Omuro A.; Taillandier L.; Chinot O. et al. Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? J Neurooncol. 2011; 104 (1): 323-30. 20. Omuro A.M.; Taillandier L.; Chinot O. et al. Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly. J Neurooncol. 2007; 85(2): 207-211. 21. Rubenstein J.; Ferreri A.J.; Pittaluga S. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma. 2008; 49(suppl.1): 43-512. 22. Rubenstein J.L.; Hsi E.D.; Johnson J.L. et al. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma. J Clin Oncol. 2013; 31(25): 3061-8. 23. Schultz C.J.; Bovi J. Current management of primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys. 2010; 76 (3): 666-78. 24. Thiel E.; Korfel A.; Martus P. et al. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, noninferiority trial. Lancet Oncol. 2010; 11(11): 1036-47. 25. Wieduwilt M.J.; Valles F.; Issa S. et al. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012; 18(4): 1146-55.